-
Selegiline, also
known as L-deprenyl and sold
under the
brand names Eldepryl, Zelapar, and
Emsam among others, is a
medication which is used in the treatment...
-
pharmacology of
selegiline pertains to the
pharmacodynamic and
pharmacokinetic properties of the
antiparkinsonian and
antidepressant selegiline (L-deprenyl)...
- (PPAP;
developmental code name MK-306) is an
experimental drug
related to
selegiline which acts as a
catecholaminergic activity enhancer (CAE). PPAP is a CAE...
-
complicated by
panic disorder or
hysteroid dysphoria.
Newer MAOIs such as
selegiline (typically used in the
treatment of Parkinson's disease) and the reversible...
-
levoamphetamine is a
known active metabolite of
certain other drugs, such as
selegiline (L-deprenyl).
Levoamphetamine has been used in the
treatment of attention...
-
catecholamine releasing activity. It is 1- to 10-fold less
potent than
selegiline but is 3- to 5-fold more
potent than
dextromethamphetamine in this action...
- pseudoephedrine),
antidepressants (e.g. bupropion),
antiparkinson agents (e.g.,
selegiline), and
vasopressors (e.g., ephedrine),
among others. Many of
these psychoactive...
- N-propargylmethamphetamine, is the
racemic mixture of D-deprenyl and L-deprenyl (
selegiline). It was
discovered in 1961 in
Hungary at
Chinoin Pharmaceutical Company...
- brain.
Rasagiline shows pharmacological differences from the
related drug
selegiline,
including having no amphetamine-like metabolites, monoamine-releasing...
-
serotonergic activity.
Selegiline's metabolite desmethylselegiline has also been
found to be
active as a CAE.
Aside from
selegiline and its metabolites,...
